These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6323960)

  • 1. Characteristics of an ADP receptor mediating platelet activation.
    Colman RW; Figures WR
    Mol Cell Biochem; 1984; 59(1-2):101-11. PubMed ID: 6323960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding.
    Figures WR; Scearce LM; Wachtfogel Y; Chen J; Colman RF; Colman RW
    J Biol Chem; 1986 May; 261(13):5981-6. PubMed ID: 3009439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
    J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence for the interaction of the nucleotide affinity analog 5'-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptor.
    Figures WR; Scearce LM; DeFeo P; Stewart G; Zhou F; Chen J; Daniel J; Colman RF; Colman RW
    Blood; 1987 Sep; 70(3):796-803. PubMed ID: 3040157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregin: a platelet ADP receptor that mediates activation.
    Colman RW
    FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
    Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
    Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
    Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
    Trans Assoc Am Physicians; 1986; 99():39-45. PubMed ID: 3603928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis of the platelet surface: dissociation of shape change from aggregation.
    Kornecki E; Ehrlich YH; Hardwick DH; Lenox RH
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H550-7. PubMed ID: 3008579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'-p-fluorosulfonylbenzoyladenosine is a weak platelet agonist.
    Rao AK; Kowalska MA
    Blood; 1987 Sep; 70(3):751-6. PubMed ID: 3040154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.